Juvenile Dermatomyositis

• CLINICAL_TRIALS trial_result · 2026-04-23
  Clinical Trial Update: Baricitinib in the Treatment of New-onset Juvenile Dermatomyositis (MYOCIT) [Phase 2]

  A Phase 2 clinical trial evaluating baricitinib for new-onset juvenile dermatomyositis has completed.

• CLINICAL_TRIALS trial_result · 2026-04-01
  Clinical Trial Update: Comparison Of The Effects Of Two Different Exercise Training Based On Internal And External Focus In Children and Adolescents With Rheumatic Diseases [NA]

  Completed study comparing two exercise training approaches (internal vs external focus) in children and adolescents with rheumatic diseases,…

• CLINICAL_TRIALS trial_result · 2026-02-11
  Clinical Trial Update: Transition to Adulthood Through Coaching and Empowerment in Rheumatology [NA]

  A completed study evaluating a coaching and empowerment program to help youths with juvenile rheumatic diseases transition to adulthood.

• CLINICAL_TRIALS trial_result · 2025-08-28
  Clinical Trial Update: Fitness Integrative Training for Pediatric Rheumatology Disorders [NA]

  The trial update reports completion of a study evaluating fitness integrative training for pediatric rheumatology disorders. The study inclu…

• CLINICAL_TRIALS trial_result · 2025-08-22
  Clinical Trial Update: COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders [Phase 2]

  This Phase 2 trial evaluating a COVID-19 booster vaccine in autoimmune-disease non-responders was terminated, with results posted on 2025-08…

• Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
• CLINICAL_TRIALS trial_result · 2024-06-11
  Clinical Trial Update: Efficacy and Safety of H.P. Acthar Gel for the Treatment of Refractory Cutaneous Manifestations of Dermatomyositis [Phase 4]

  A Phase 4 clinical trial update reports on the efficacy and safety of Acthar Gel (repository corticotropin injection) for refractory cutaneo…

• CLINICAL_TRIALS trial_result · 2021-03-16
  Clinical Trial Update: Five-year Actively Controlled Clinical Trial in New Onset Juvenile Dermatomyositis [Phase 3]

  A five-year actively controlled Phase 3 trial in new onset juvenile dermatomyositis has completed enrollment with results posted in 2021.

• CLINICAL_TRIALS trial_result · 2018-05-11
  Clinical Trial Update: The Effect of Creatine Supplementation on Muscle Function in Childhood Myositis [NA]

  A completed clinical trial assessed the effect of creatine supplementation on muscle function in children with juvenile dermatomyositis.

• CLINICAL_TRIALS trial_result · 2017-11-13
  Clinical Trial Update: Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease [Phase 4]

  Phase 4 clinical trial evaluating the immune response to HPV vaccination in patients with autoimmune diseases. The study includes Juvenile I…

• CLINICAL_TRIALS trial_result · 2015-03-04
  Clinical Trial Update: Rituximab for the Treatment of Refractory Adult and Juvenile Dermatomyositis (DM) and Adult Polymyositis (PM) [Phase 2]

  Phase 2 trial evaluating rituximab for refractory adult and juvenile dermatomyositis and adult polymyositis; results have been posted.

• CLINICAL_TRIALS trial_result · 2011-07-22
  Clinical Trial Update: Absorption of Corticosteroids in Children With Juvenile Dermatomyositis [Phase 2]

  A Phase 2 clinical trial update evaluating how corticosteroids are absorbed in children with juvenile dermatomyositis, with the study status…